CryoPort Inc header image

CryoPort Inc

CYRX

Equity

ISIN null / Valor 28284615

NASDAQ (2026-03-27)
USD 7.82-4.75%

CryoPort Inc
UMushroom community rating:

star star star star star
2.50 2 votes No rating yet
NegativeNeutralPositive

About company

CryoPort Inc is a specialized logistics and supply chain solutions provider focused on serving the life sciences industry. Established by a team of doctors, the company has significantly expanded its offerings beyond its initial logistics support to encompass a comprehensive suite of supply chain solutions. These solutions cater to various stages of the life sciences research, development, and manufacturing processes. As a standalone vendor, CryoPort supports the entire temperature-controlled supply chain, ensuring the safe and efficient transport of sensitive biological materials. The company's Integrated BioServices solutions are designed to address the complex needs of advanced therapies, ranging from clinical trials to commercial material management. Additionally, CryoPort's IntegriCell cryopreservation services offer standardized protocols, processes, and equipment, focusing on the provision of consistent, high-quality leukapheresis starting material. This broad range of services positions CryoPort as a key partner for organizations within the life sciences sector, seeking reliable support for their critical supply chain and logistics needs.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

25.3%1Y
-65.2%3Y
-84.9%5Y

Performance

69.7%1Y
79.0%3Y
77.0%5Y

Volatility

Market cap

390 M

Market cap (USD)

Daily traded volume (Shares)

320,278

Daily traded volume (Shares)

1 day high/low

7.98 / 7.48

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

2.50

2 votes
Performance:
starstarstarstarstar
2.50
Innovation:
starstarstarstarstar
2.50
Society:
starstarstarstarstar
2.50
Nature:
starstarstarstarstar
2.50
Tilly Chapman
United Kingdom, 26 Oct 2025
star star star star star
decent performance so far
Mathias Dirksmeier
Switzerland, 25 Mar 2025
star star star star star
No

EQUITIES OF THE SAME SECTOR

Intra-Cellular Therapies Inc
Intra-Cellular Therapies Inc Intra-Cellular Therapies Inc Valor: 23194616
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 131.87
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.98%USD 18.16
GE Healthcare Technologies Inc
GE Healthcare Technologies Inc GE Healthcare Technologies Inc Valor: 123735674
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.23%USD 69.23
Option Care Health Inc
Option Care Health Inc Option Care Health Inc Valor: 52359365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.73%USD 27.27
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.56%EUR 26.00
Laboratorios Farmaceuticos Rovi, SA
Laboratorios Farmaceuticos Rovi, SA Laboratorios Farmaceuticos Rovi, SA Valor: 3591807
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.57%EUR 78.90
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.10%CHF 312.50
Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc Madrigal Pharmaceuticals Inc Valor: 33395434
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.56%USD 510.68
Evotec SE
Evotec SE Evotec SE Valor: 505433
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.60%EUR 4.30
Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc Syndax Pharmaceuticals Inc Valor: 24112479
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.90%USD 23.49